Integrated Filing — IndAS

General information about company
Scrip Code	543654
NSE Symbol	MEDANTA
MSEI Symbol	NOTLISTED
ISIN	INE474Q01031
Name of company	GLOBAL HEALTH LIMITED
Type of company	Main Board
Class of security	Equity
Date of start of financial year	01-Apr-2024
Date of end of financial year	31-Mar-2025
Date of board meeting when results were approved	15-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	05-May-2025
Description of presentation currency	INR (in Actuals)
Reporting Type	Quarterly
Reporting Quarter	Fourth quarter
Nature of report standalone or consolidated	Consolidated
Whether results are audited or unaudited for the quarter ended	Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended	Audited
Segment Reporting	Single segment
Description of single segment	Healthcare services
Start date and time of board meeting	15-May-2025   14:00:00
End date and time of board meeting	15-May-2025   16:00:00
Whether cash flow statement is applicable on company	Yes
Type of cash flow statement	Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification	Declaration of unmodified opinion

Financial Results Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Consolidated	Consolidated
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1	Income
	Revenue from operations	9312470000	36923150000
	Other income	229300000	790970000
	Total income	9541770000	37714120000
2	Expenses
(a)	Cost of materials consumed	1914790000	7899600000
(b)	Purchases of stock-in-trade	205110000	924610000
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	16290000	-27520000
(d)	Employee benefit expense	2040540000	8245420000
(e)	Finance costs	150300000	652590000
(f)	Depreciation, depletion and amortisation expense	492540000	1937480000
(f)	Other Expenses
1	Retainers and consultants fee	1315920000	4973430000
2	Other expenses	1572940000	6136980000
	Total other expenses	2888860000	11110410000
	Total expenses	7708430000	30742590000
3	Total profit before exceptional items and tax	1833340000	6971530000
4	Exceptional items	-498960000	-498960000
5	Total profit before tax	1334380000	6472570000
6	Tax expense
7	Current tax	368650000	1615530000
8	Deferred tax	-48050000	43860000
9	Total tax expenses	320600000	1659390000
10	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0	0
11	Net Profit Loss for the period from continuing operations	1013780000	4813180000
12	Profit (loss) from discontinued operations before tax	0	0
13	Tax expense of discontinued operations	0	0
14	Net profit (loss) from discontinued operation after tax	0	0
15	Share of profit (loss) of associates and joint ventures accounted for using equity method	0	0
16	Total profit (loss) for period	1013780000	4813180000
17	Other comprehensive income net of taxes	-22740000	-6700000
18	Total Comprehensive Income for the period	991040000	4806480000
19	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent	1014000000	4814370000
	Total profit or loss, attributable to non-controlling interests	-220000	-220000
20	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent	-22740000	-6700000
	Total comprehensive income for the period attributable to owners of parent non-controlling interests	0	0
21	Details of equity share capital
	Paid-up equity share capital	537170000	537170000
	Face value of equity share capital	2	2
27	Details of debt securities
22	Reserves excluding revaluation reserve		33326930000
23	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	3.77	17.92
	Diluted earnings (loss) per share from continuing operations	3.77	17.92
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	3.77	17.92
	Diluted earnings (loss) per share from continuing and discontinued operations	3.77	17.92
24	Debt equity ratio
25	Debt service coverage ratio
26	Interest service coverage ratio
27	Disclosure of notes on financial results

Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio

Statement of Asset and Liabilities
Particulars		Year ended (dd-mm-yyyy)
Date of start of reporting period		01-Apr-2024
Date of end of reporting period		31-Mar-2025
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Consolidated
	Assets
1	Non-current assets
	Property, plant and equipment	19752640000
	Capital work-in-progress	5285210000
	Investment property	0
	Goodwill	0
	Other intangible assets	64690000
	Intangible assets under development	48160000
	Biological assets other than bearer plants	0
	Investments accounted for using equity method	0
	Non-current financial assets
	Non-current investments	27100000
	Trade receivables, non-current
	Loans, non-current	0
	Other non-current financial assets	300480000
	Total non-current financial assets	327580000
	Deferred tax assets (net)	330230000
	Other non-current assets	6522560000
	Total non-current assets	32331070000
2	Current assets
	Inventories	671410000
	Current financial asset
	Current investments	0
	Trade receivables, current	2918560000
	Cash and cash equivalents	2302000000
	Bank balance other than cash and cash equivalents	8921350000
	Loans, current	0
	Other current financial assets	327980000
	Total current financial assets	14469890000
	Current tax assets (net)	0
	Other current assets	189930000
	Total current assets	15331230000
3	Non-current assets classified as held for sale	0
4	Regulatory deferral account debit balances and related deferred tax Assets	0
	Total assets	47662300000
	Equity and liabilities
1	Equity
	Equity attributable to owners of parent
	Equity share capital	537170000
	Other equity	33326930000
	Total equity attributable to owners of parent	33864100000
	Non controlling interest	10970000
	Total equity	33875070000
2	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	2641000000
	Trade payables, non-current
	(A) Total outstanding dues of micro enterprises and small enterprises	0
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	0
	Total Trade payable	0
	Other non-current financial liabilities	4075220000
	Total non-current financial liabilities	6716220000
	Provisions, non-current	661680000
	Deferred tax liabilities (net)	0
	Deferred government grants, Non-current	0
	Other non-current liabilities	221160000
	Total non-current liabilities	7599060000
	Current liabilities
	Current financial liabilities
	Borrowings, current	637830000
	Trade payables, current
	(A) Total outstanding dues of micro enterprises and small enterprises	793650000
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	1154470000
	Total Trade payable	1948120000
	Other current financial liabilities	1616400000
	Total current financial liabilities	4202350000
	Other current liabilities	1511840000
	Provisions, current	473980000
	Current tax liabilities (Net)	0
	Deferred government grants, Current	0
	Total current liabilities	6188170000
3	Liabilities directly associated with assets in disposal group classified as held for sale	0
4	Regulatory deferral account credit balances and related deferred tax liability	0
	Total liabilities	13787230000
	Total equity and liabilites	47662300000
	Disclosure of notes on assets and liabilities

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-Jan-2025	01-Apr-2024
Date of end of reporting period		31-Mar-2025	31-Mar-2025
Whether accounts are audited or unaudited		Audited	Audited
Nature of report standalone or consolidated		Consolidated	Consolidated
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
	Total Segment Revenue
	Less: Inter segment revenue
	Revenue from operations
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
	Total Profit before tax
	i. Finance cost
	ii. Other Unallocable Expenditure net off Unallocable income
	Profit before tax
3	(Segment Asset - Segment Liabilities)
	Segment Asset
	Total Segment Asset
	Un-allocable Assets	null	null
	Net Segment Asset	null	null
4	Segment Liabilities
	Segment Liabilities
	Total Segment Liabilities
	Un-allocable Liabilities	null	null
	Net Segment Liabilities	null	null
	Disclosure of notes on segments

Other Comprehensive Income
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Consolidated	Consolidated
	Other comprehensive income [Abstract]
1	Amount of items that will not be reclassified to profit and loss
1	Items that will not be reclassified to statement of profit or loss	-30460000	-9130000
	Total Amount of items that will not be reclassified to profit and loss	-30460000	-9130000
2	Income tax relating to items that will not be reclassified to profit or loss	-7720000	-2430000
3	Amount of items that will be reclassified to profit and loss
	Total Amount of items that will be reclassified to profit and loss
4	Income tax relating to items that will be reclassified to profit or loss
5	Total Other comprehensive income	-22740000	-6700000

Cash flow statement, indirect
Particulars				Year ended (dd-mm-yyyy)
A	Date of start of reporting period			2024-04-01
B	Date of end of reporting period			2025-03-31
C	Whether results are audited or unaudited			Audited
D	Nature of report standalone or consolidated			Consolidated
Part I	Blue color marked fields are non-mandatory.
	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax			6472570000
	Adjustments for reconcile profit (loss)
	Adjustments for finance costs			652590000
	Adjustments for decrease (increase) in inventories			-2910000
	Adjustments for decrease (increase) in trade receivables, current			-949070000
	Adjustments for decrease (increase) in trade receivables, non-current			0
	Adjustments for decrease (increase) in other current assets			0
	Adjustments for decrease (increase) in other non-current assets			0
	Adjustments for other financial assets, non-current			0
	Adjustments for other financial assets, current			0
	Adjustments for other bank balances			0
	Adjustments for increase (decrease) in trade payables, current			125880000
	Adjustments for increase (decrease) in trade payables, non-current			0
	Adjustments for increase (decrease) in other current liabilities			0
	Adjustments for increase (decrease) in other non-current liabilities			0
	Adjustments for depreciation and amortisation expense			1937480000
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss			0
	Adjustments for provisions, current			0
	Adjustments for provisions, non-current			144710000
	Adjustments for other financial liabilities, current			0
	Adjustments for other financial liabilities, non-current			0
	Adjustments for unrealised foreign exchange losses gains			-3700000
	Adjustments for dividend income			0
	Adjustments for interest income			703180000
	Adjustments for share-based payments			0
	Adjustments for fair value losses (gains)			0
	Adjustments for undistributed profits of associates			0
	Other adjustments for which cash effects are investing or financing cash flow			0
	Other adjustments to reconcile profit (loss)			22550000
	Other adjustments for non-cash items			183030000
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships			0
	Total adjustments for reconcile profit (loss)			1407380000
	Net cash flows from (used in) operations			7879950000
	Dividends received			0
	Interest paid			0
	Interest received			0
	Income taxes paid (refund)			1642360000
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) operating activities			6237590000
	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses			0
	Cash flows used in obtaining control of subsidiaries or other businesses			0
	Other cash receipts from sales of equity or debt instruments of other entities			0
	Other cash payments to acquire equity or debt instruments of other entities			26600000
	Other cash receipts from sales of interests in joint ventures			0
	Other cash payments to acquire interests in joint ventures			0
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships			0
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships			0
	Proceeds from sales of property, plant and equipment			29940000
	Purchase of property, plant and equipment			5165450000
	Proceeds from sales of investment property			0
	Purchase of investment property			0
	Proceeds from sales of intangible assets			0
	Purchase of intangible assets			0
	Proceeds from sales of intangible assets under development			0
	Purchase of intangible assets under development			0
	Proceeds from sales of goodwill			0
	Purchase of goodwill			0
	Proceeds from biological assets other than bearer plants			0
	Purchase of biological assets other than bearer plants			0
	Proceeds from government grants			0
	Proceeds from sales of other long-term assets			0
	Purchase of other long-term assets			1313700000
	Cash advances and loans made to other parties			0
	Cash receipts from repayment of advances and loans made to other parties			0
	Cash payments for future contracts, forward contracts, option contracts and swap contracts			0
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts			0
	Dividends received			0
	Interest received			671740000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			-1405340000
	Net cash flows from (used in) investing activities	-7209410000
	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries			0
	Payments from changes in ownership interests in subsidiaries			0
	Proceeds from issuing shares			160000
	Proceeds from issuing other equity instruments			12500000
	Payments to acquire or redeem entity's shares			0
	Payments of other equity instruments			0
	Proceeds from exercise of stock options			0
	Proceeds from issuing debentures notes bonds etc			0
	Proceeds from borrowings			1491650000
	Repayments of borrowings			1834270000
	Payments of lease liabilities			105500000
	Dividends paid			0
	Interest paid			536800000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) financing activities			-972260000
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes			-1944080000
	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents			0
	Net increase (decrease) in cash and cash equivalents			-1944080000
	Cash and cash equivalents cash flow statement at beginning of period			4246080000
	Cash and cash equivalents cash flow statement at end of period			2302000000